The present invention encompasses peptides that selectively activate the VPAC2 receptor and are useful in the treatment of diabetes.

 
Web www.patentalert.com

< pH triggered targeted controlled release systems for the delivery of pharmaceutical active ingredients

> Cytomodulating peptides for treating interstitial cystitis

> Methods and compositions for treating pain
~ 00540